These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 33754286)

  • 1. Low-Level Cadmium Exposure and Atherosclerosis.
    Diaz D; Ujueta F; Mansur G; Lamas GA; Navas-Acien A; Arenas IA
    Curr Environ Health Rep; 2021 Mar; 8(1):42-53. PubMed ID: 33754286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metal pollutants and cardiovascular disease: mechanisms and consequences of exposure.
    Solenkova NV; Newman JD; Berger JS; Thurston G; Hochman JS; Lamas GA
    Am Heart J; 2014 Dec; 168(6):812-22. PubMed ID: 25458643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-Level Metal Contamination and Chelation in Cardiovascular Disease-A Ripe Area for Toxicology Research.
    Ujueta F; Navas-Acien A; Mann KK; Prashad R; Lamas GA
    Toxicol Sci; 2021 May; 181(2):135-147. PubMed ID: 33662137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential Role of Metal Chelation to Prevent the Cardiovascular Complications of Diabetes.
    Calderon Moreno R; Navas-Acien A; Escolar E; Nathan DM; Newman J; Schmedtje JF; Diaz D; Lamas GA; Fonseca V
    J Clin Endocrinol Metab; 2019 Jul; 104(7):2931-2941. PubMed ID: 30869793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heavy Metals, Cardiovascular Disease, and the Unexpected Benefits of Chelation Therapy.
    Lamas GA; Navas-Acien A; Mark DB; Lee KL
    J Am Coll Cardiol; 2016 May; 67(20):2411-2418. PubMed ID: 27199065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic Toxic Metal Exposure and Cardiovascular Disease: Mechanisms of Risk and Emerging Role of Chelation Therapy.
    Aneni EC; Escolar E; Lamas GA
    Curr Atheroscler Rep; 2016 Dec; 18(12):81. PubMed ID: 27822681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chelation therapy to prevent diabetes-associated cardiovascular events.
    Diaz D; Fonseca V; Aude YW; Lamas GA
    Curr Opin Endocrinol Diabetes Obes; 2018 Aug; 25(4):258-266. PubMed ID: 29846236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chelation Therapy as a Cardiovascular Therapeutic Strategy: the Rationale and the Data in Review.
    Mathew RO; Schulman-Marcus J; Nichols EL; Newman JD; Bangalore S; Farkouh M; Sidhu MS
    Cardiovasc Drugs Ther; 2017 Dec; 31(5-6):619-625. PubMed ID: 29129003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EDTA Chelation Therapy to Reduce Cardiovascular Events in Persons with Diabetes.
    Ouyang P; Gottlieb SH; Culotta VL; Navas-Acien A
    Curr Cardiol Rep; 2015 Nov; 17(11):96. PubMed ID: 26364188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heavy Metal Toxicity in Chronic Renal Failure and Cardiovascular Disease: Possible Role for Chelation Therapy.
    Glicklich D; Shin CT; Frishman WH
    Cardiol Rev; 2020; 28(6):312-318. PubMed ID: 32040019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baseline characteristics including blood and urine metal levels in the Trial to Assess Chelation Therapy 2 (TACT2).
    Navas-Acien A; Santella RM; Joubert BR; Huang Z; Lokhnygina Y; Ujueta F; Gurvich I; LoIacono NJ; Ravalli F; Ward CD; Jarrett JM; Salazar AL; Boineau R; Jones TLZ; Mark DB; Newman JD; Nathan DM; Anstrom KJ; Lamas GA
    Am Heart J; 2024 Jul; 273():72-82. PubMed ID: 38621575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A TACTful reappraisal of chelation therapy in cardiovascular disease.
    Sidhu MS; Saour BM; Boden WE
    Nat Rev Cardiol; 2014 Mar; 11(3):180-3. PubMed ID: 24343569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chelation therapy in cardiovascular disease: an update.
    Sultan S; Murarka S; Jahangir A; Mookadam F; Tajik AJ; Jahangir A
    Expert Rev Clin Pharmacol; 2017 Aug; 10(8):843-854. PubMed ID: 28597699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chelation therapy to treat atherosclerosis, particularly in diabetes: is it time to reconsider?
    Lamas GA; Ergui I
    Expert Rev Cardiovasc Ther; 2016 Aug; 14(8):927-38. PubMed ID: 27149141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Environment and cardiovascular health: causes, consequences and opportunities in prevention and treatment.
    Bañeras J; Iglesies-Grau J; Téllez-Plaza M; Arrarte V; Báez-Ferrer N; Benito B; Campuzano Ruiz R; Cecconi A; Domínguez-Rodríguez A; Rodríguez-Sinovas A; Ujueta F; Vozzi C; Lamas GA; Navas-Acién A
    Rev Esp Cardiol (Engl Ed); 2022 Dec; 75(12):1050-1058. PubMed ID: 35931285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic Cadmium Exposure Accelerates the Development of Atherosclerosis and Induces Vascular Dysfunction in the Aorta of ApoE
    Oliveira TF; Batista PR; Leal MA; Campagnaro BP; Nogueira BV; Vassallo DV; Meyrelles SS; Padilha AS
    Biol Trace Elem Res; 2019 Jan; 187(1):163-171. PubMed ID: 29707746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The proinflammatory activity of cadmium].
    Mlynek V; Skoczyńska A
    Postepy Hig Med Dosw (Online); 2005; 59():1-8. PubMed ID: 15761380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Case For Cadmium and Lead Heavy Metal Screening.
    Glicklich D; Frishman WH
    Am J Med Sci; 2021 Oct; 362(4):344-354. PubMed ID: 34048724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative Stress and Cardiovascular Dysfunction Associated with Cadmium Exposure: Beneficial Effects of Curcumin and Tetrahydrocurcumin.
    Kukongviriyapan U; Apaijit K; Kukongviriyapan V
    Tohoku J Exp Med; 2016 May; 239(1):25-38. PubMed ID: 27151191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The search for chelate antagonists for chronic cadmium intoxication.
    Jones MM; Cherian MG
    Toxicology; 1990 May; 62(1):1-25. PubMed ID: 2188397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.